X0306 4 2018-02-27 0 0001180262 HERBALIFE LTD. HLF 0001472187 Hienrich Edi 800 W. OLYMPIC BLVD. SUITE 406 LOS ANGELES CA 90015 0 1 0 0 SVP/Managing Director EMEA Common Stock 2018-02-27 4 M 0 16250 53.29 A 28684 D Common Stock 2018-02-27 4 D 0 9995 86.64 D 18689 D Common Stock 2018-02-27 4 F 0 3415 86.64 D 15274 D Common Stock 2018-02-27 4 M 0 24590 44.79 A 39864 D Common Stock 2018-02-27 4 D 0 12713 86.64 D 27151 D Common Stock 2018-02-27 4 F 0 6485 86.64 D 20666 D Common Stock 2018-02-27 4 M 0 19245 59.98 A 39911 D Common Stock 2018-02-27 4 D 0 13324 86.64 D 26587 D Common Stock 2018-02-27 4 F 0 3234 86.64 D 23353 D Common Stock 2018-02-27 4 M 0 6697 37.70 A 30050 D Common Stock 2018-02-27 4 D 0 2915 86.64 D 27135 D Common Stock 2018-02-27 4 F 0 2066 86.64 D 25069 D Common Stock 2018-02-27 4 M 0 13050 30.44 A 38119 D Common Stock 2018-02-27 4 D 0 4586 86.64 D 33533 D Common Stock 2018-02-27 4 F 0 4622 86.64 D 28911 D Common Stock 2018-02-27 4 M 0 5000 47.80 A 33911 D Common Stock 2018-02-27 4 D 0 2760 86.64 D 31151 D Common Stock 2018-02-27 4 F 0 1224 86.64 D 29927 D Common Stock 2018-02-27 4 M 0 4237 22.94 A 5627 I By Wife Common Stock 2018-02-27 4 D 0 1122 86.64 D 4505 I by Wife Common Stock 2018-02-27 4 F 0 1567 86.64 D 2938 I by Wife Common Stock 2018-02-27 4 M 0 3472 53.29 A 6410 I by Wife Common Stock 2018-02-27 4 D 0 2136 86.64 D 4274 I by Wife Common Stock 2018-02-27 4 F 0 672 86.64 D 3602 I by Wife Common Stock 2018-02-27 4 M 0 5409 44.79 A 9011 I by Wife Common Stock 2018-02-27 4 D 0 2797 86.64 D 6214 I by Wife Common Stock 2018-02-27 4 F 0 1314 86.64 D 4900 I by Wife Common Stock 2018-02-27 4 M 0 3464 59.98 A 8364 I by Wife Common Stock 2018-02-27 4 D 0 2399 86.64 D 5965 I by Wife Common Stock 2018-02-27 4 F 0 536 86.64 D 5429 I by Wife Stock Appreciation Rights 53.29 2018-02-27 4 M 0 16250 0.00 D 2014-05-18 2021-05-18 Common Stock 16250 0 D Stock Appreciation Rights 44.79 2018-02-27 4 M 0 24590 0.00 D 2015-05-31 2022-05-21 Common Stock 24590 0 D Stock Appreciation Rights 59.98 2018-02-27 4 M 0 19245 0.00 D 2017-04-30 2024-04-30 Common Stock 19245 0 D Stock Appreciation Rights 37.70 2018-02-27 4 M 0 6697 0.00 D 2018-01-01 2025-01-01 Common Stock 6697 0 D Stock Appreciation Rights 30.44 2018-02-27 4 M 0 13050 0.00 D 2017-03-02 2025-03-02 Common Stock 13050 19576 D Stock Appreciation Rights 47.80 2018-02-27 4 M 0 5000 0.00 D 2017-05-07 2025-05-07 Common Stock 5000 7500 D Stock Appreciation Rights 22.94 2018-02-27 4 M 0 4237 0.00 D 2013-05-07 2020-05-07 Common Stock 4237 0 I By Wife Stock Appreciation Rights 53.29 2018-02-27 4 M 0 3472 0.00 D 2014-05-18 2021-05-18 Common Stock 3472 0 I By Wife Stock Appreciation Rights 44.79 2018-02-27 4 M 0 5409 0.00 D 2015-05-31 2022-05-31 Common Stock 5409 0 I By Wife Stock Appreciation Rights 59.98 2018-02-27 4 M 0 3464 0.00 D 2017-04-30 2024-04-30 Common Stock 3464 0 I By Wife The reporting person received 2,840 shares of common stock upon the net exercise of 16,250 stock appreciation rights ("SARs"). The reporting person forfeited 9,995 shares of common stock underlying the SARs in payment of the exercise price and 3,415 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64. The reporting person received 5,392 shares of common stock upon the net exercise of 24,590 SARs. The reporting person forfeited 12,713 shares of common stock underlying the SARs in payment of the exercise price and 6,485 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64. The reporting person received 2,687 shares of common stock upon the net exercise of 19,245 SARs . The reporting person forfeited 13,324 shares of common stock underlying the SARs in payment of the exercise price and 3,234 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64. The reporting person received 1,716 shares of common stock upon the net exercise of 6,697 SARs. The reporting person forfeited 2,915 shares of common stock underlying the SARs in payment of the exercise price and 2,066 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64. The reporting person received 3,842 shares of common stock upon the net exercise of 13,050 SARs. The reporting person forfeited 4,586 shares of common stock underlying the SARs in payment of the exercise price and 4,622 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64. The reporting person received 1,016 shares of common stock upon the net exercise of 5,000 SARs. The reporting person forfeited 2,760 shares of common stock underlying the SARs in payment of the exercise price and 1,224 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64. The reporting person's wife received 1,548 shares of common stock upon the net exercise of 4,237 SARs . The reporting person forfeited 1,122 shares of common stock underlying the SARs in payment of the exercise price and 1,567 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64. The reporting person's wife received 664 shares of common stock upon the net exercise of 3,472 SARs. The reporting person forfeited 2,136 shares of common stock underlying the SARs in payment of the exercise price and 672 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64. The reporting person's wife received 1,298 shares of common stock upon the net exercise of 5,409 SARs. The reporting person forfeited 2,797 shares of common stock underlying the SARs in payment of the exercise price and 1,314 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64. The reporting person's wife received 529 shares of common stock upon the net exercise of 3,464 SARs. The reporting person forfeited 2,399 shares of common stock underlying the SARs in payment of the exercise price and 536 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64. Consists of SARs granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on each of March 2, 2016 and March 2, 2017, and the remaining 60% will vest March 2, 2018. Consists of SARs granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on each of May 7, 2016 and May 7, 2017, and the remaining 60% will vest May 7, 2018. /s/ Eileen Uy, Attorney-in-Fact for Edi Hienrich 2018-03-01